New (chalcogenoethyl)ferrocenylcarboxalate functionalized silver chalcogenide nanoclusters were synthesized using a combination of silylated chalcogen reagents at low temperatures. The addition of E(SiMe(3))(2) to reaction mixtures of FcC{O}OCH(2)CH(2)ESiMe(3) (E = S, Se) and (Ph(3)P)(2)·AgOAc affords nanoclusters with approximate molecular formulas [Ag(36)S(9)(SCH(2)CH(2)O{O}CFc)(18)(PPh(3))(3)] (1), [Ag(100)Se(17)(SeCH(2)CH(2)O{O}CFc)(66)(PPh(3))(10)] (2), and [Ag(180)Se(54)(SeCH(2)CH(2)O{O}CFc)(72)(PPh(3))(14)] (3) as noncrystalline solids. Compositions were formulated on the basis of elemental analysis, high resolution transmission electron microscopy, and dynamic light scattering experiments. Solutions of these polyferrocenyl assemblies display a single quasi-reversible redox wave with some adsorption to the electrode surface as studied by cyclic voltammetry. With the smaller clusters 1, the addition of [Bu(4)N][HSO(4)] results in a shift of the reduction wave to less positive potentials than those of the complex in the absence of these oxoanions. No further shift is observed after the addition of approximately 1 equivalent of HSO(4)(-)/ferrocene branch. Cyclic voltammograms of the larger clusters 2 and 3 show the appearance of a new, irreversible wave at less positive potentials than the initial wave upon the addition of HSO(4)(-). The appearance of this new wave together with the disappearance of the reduction wave indicates a stronger interaction between the nanoclusters and the hydrogen sulfate anion.
No takes yet. Share an insight, caveat, or question.
MacDonald et al. (2011) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: